Health Aptose Reports Results for the First Quarter 2023 Jason Junior May 9, 2023 <!-- Name:DistributionId Value:8834370 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…
Health Aptose Initiates Dosing of Tuspetinib in APTIVATE Expansion Trial in Patients with Acute Myeloid… Jason Junior Jan 30, 2023 <!-- Name:DistributionId Value:8738171 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…